← Eichor
Study identifier: NCT04684147 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia

Condition: Relapsed or Refractory Acute Lymphoblastic Leukemia  ·  Sponsor: Juventas Cell Therapy Ltd.

PhasePhase 2
Planned participants100
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

The study is a Phase II, single-arm, open-label, single-dose clinical trial, and its primary objective is to evaluate the efficacy and safety of CNCT19 Cell Injection in the treatment of CD19 positive Relapsed or Refractory acute lymphoblastic leukemia.

This description comes directly from the study's public registry record.

Talk to the study team

Yan Zhou  ·  +86-15010390127  ·  zhouyan@juventas.cn

Always discuss trial participation with your own doctor first.

Locations (11)

Beijing Boren HospitalBeijing, Beijing Municipality, ChinaRecruiting
Xinqiao Hospital of TMMUChongqing, Chongqing Municipality, ChinaRecruiting
Nanfang HospitalGuangzhou, Guangdong, ChinaRecruiting
Yanda hospital, Hebei medical universitySanhe, Hebei, ChinaNot Yet Recruiting
Henan Cancer HospitalZhengzhou, Henan, ChinaRecruiting
Union Hospital Tongji Medical College Huazhong University of Science and TechnologyWuhan, Hubei, ChinaRecruiting
The affiliated hospital of Xuzhou medical universityXuzhou, Jiangsu, ChinaRecruiting
Tongji Hospital of Tongji UniversityShanghai, Shanghai Municipality, ChinaRecruiting
West China Hospital，Sichuan UniversityChengdu, Sichuan, ChinaRecruiting
Institute of Hematology & Blood Diseases HospitalTianjin, Tianjin Municipality, ChinaRecruiting
The First Affiliated Hospital, Zhejiang University school of MedicineHangzhou, Zhejiang, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04684147